Urologic Oncology: Clinical Diagnosis and Treatment

Dear Colleagues,

Urologic oncology stands at the forefront of medical research and innovation. As advancements in technology and medical understanding continue to accelerate, the landscape of urologic oncology is undergoing profound transformations. Clinicians, researchers, and patients are now faced with an array of diagnostic tools, therapeutic approaches, and personalized treatment options, raising crucial questions about the most effective strategies used for diagnosis and treatment. This field encompasses a range of cancers, including (but not limited to) prostate, bladder, kidney, and testicular cancers, each presenting unique challenges and opportunities for medical intervention.

This Special Issue seeks to bridge the gap between cutting-edge research and its translation into optimal patient care. By scrutinizing the latest diagnostic techniques, exploring novel biomarkers, evaluating the efficacy of existing treatments, and investigating emerging therapies, this edition aims to highlight the path towards enhanced clinical outcomes and improved quality of life for patients grappling with urologic malignancies.

Dr. Jesús Moreno-Sierra
Dr. Juan Gómez Rivas
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• diagnosis
• prognosis
• urological tumors
• urological cancer
• uro-oncology
• prostate cancer
• kidney cancer
• bladder cancer
• testicular cancer
• penile cancer
• screening
• surgery
• treatment